Background illustration for clinical trials search

Paid Clinical Trials Oklahoma City

Discover 572 paid clinical trials in Oklahoma City, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

for
Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation
Location: Oklahoma City OK, Dallas TX, Fort Worth TX,
Sponsor: Chris Goss

Sex: All

Age: 6+

Code: NCT05548283

Recruiting
Active & Responsive

The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).

for
Intracranial Aneurysm
Location: Oklahoma City OK, Memphis TN, Englewood CO,
Sponsor: Medtronic Neurovascular Clinical Affairs

Sex: All

Age: 18 - 70+

Code: NCT02998229

Recruiting
Active & Responsive

Postnatal Exercise to Activate Baby's Brown Fat

for
Childhood Obesity Prevention, Childhood Obesity,
Location: Oklahoma City OK, Boston MA
Sponsor: Joslin Diabetes Center

Sex: Female

Age: 18 - 45

Code: NCT07467694

Recruiting
Active & Responsive

Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial

for
Lupus Nephritis
Location: Oklahoma City OK, Fort Worth TX, Atlanta GA,
Sponsor: NephroNet, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07225387

Recruiting
Active & Responsive

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

for
Primary Sjogren's Disease
Location: Oklahoma City OK, Allen TX, Fort Worth TX, Euless TX,
Sponsor: Vor Biopharma

Sex: All

Age: 18 - 70+

Code: NCT07404865

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease

for
Systemic Lupus Erythematosus
Location: Oklahoma City OK, Atlanta GA, San Diego CA, Hershey PA,
Sponsor: NYU Langone Health

Sex: All

Age: 55+

Code: NCT05799378

Phase 3, Recruiting
Active & Responsive

Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease

for
Chronic Granulomatous Disease (CGD)
Location: Oklahoma City OK, Topeka KS, Little Rock AR, Austin TX,
Sponsor: Ensoma

Sex: All

Age: 0+

Code: NCT06605378

Recruiting
Active & Responsive

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

for
Alzheimer Disease
Location: Oklahoma City OK, Irving TX, DeSoto TX, Austin TX,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Sex: All

Age: 55 - 70+

Code: NCT06585787

Phase 3, Recruiting
Active & Responsive

A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)

for
Insomnia
Location: Oklahoma City OK, DeSoto TX, Houston TX, Savannah GA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18 - 70

Code: NCT06655883

Phase 3, Recruiting
Active & Responsive

Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

for
Schizophrenia
Location: Oklahoma City OK, Fort Worth TX, Bryant AR, Lincoln NE,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07379827

Recruiting
Active & Responsive

A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors

for
Solid Tumor
Location: Oklahoma City OK, Dallas TX, Nashville TN,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18+

Code: NCT06384807

Phase 1, Phase 2, Recruiting
Active & Responsive

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

for
Heart Failure, Heart Diseases, Cardiovascular Diseases,
Location: Oklahoma City OK, Tulsa OK, Plano TX, Dallas TX,
Sponsor: Abbott Medical Devices

Sex: All

Age: 18+

Code: NCT06526195

Recruiting
Active & Responsive

A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001).

for
Healthy
Location: Oklahoma City OK, Springfield MO, Kansas City MO,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 12 - 30

Code: NCT06655324

Phase 1, Recruiting
Active & Responsive

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

for
Overweight , Obesity, Adults
Location: Oklahoma City OK, Irving TX, Tomball TX, San Antonio TX,
Sponsor: Alveus Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07837973

Phase 2, Recruiting
Active & Responsive

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

for
Obesity or Overweight
Location: Oklahoma City OK, Chickasha OK, McKinney TX,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07575399

Phase 3, Recruiting
Active & Responsive

Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus

for
Type II Diabetes Mellitus
Location: Oklahoma City OK, El Dorado KS, Newton KS,
Sponsor: Sun Pharmaceutical Industries Limited

Sex: All

Age: 18+

Code: NCT07282743

Phase 2, Recruiting
Active & Responsive

Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

for
Sjögren´s Disease
Location: Oklahoma City OK, Euless TX, Leander TX, Houston TX,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07621809

Phase 3, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

for
NASH - Nonalcoholic Steatohepatitis,
Location: Oklahoma City OK, Wichita Falls TX, Denison TX,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06528314

Phase 3, Recruiting
Active & Responsive

Motiva Implants® Post-Approval Study

for
Breast Implant
Location: Oklahoma City OK, Tulsa OK, Southlake TX, Dallas TX,
Sponsor: Motiva USA LLC

Sex: Female

Age: 22+

Code: NCT06938399

Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

for
Crohn's Disease
Location: Oklahoma City OK, Southlake TX, Dallas TX, Denton TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 16 - 70+

Code: NCT06430801

Phase 3, Recruiting